![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lavigne Patrick Benderdour Mohamed Shi Qin Lajeunesse Daniel Fernandes Julio C
Publisher: Informa Healthcare
ISSN: 1471-2598
Source: Expert Opinion on Biological Therapy, Vol.5, Iss.3, 2005-03, pp. : 313-320
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New therapeutic agents for the treatment of bone diseases
By Lipton Allan
Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MicroRNA, Vol. 2, Iss. 1, 2013-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Follistatin as a potent regulator of bone metabolism
By Gajos-Michniewicz A. Piastowska A. W. Russell J. A. Ochedalski T.
Biomarkers, Vol. 15, Iss. 7, 2010-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Liu Gang Men Ping Kenner Gerry Miller Scott
BioMetals, Vol. 19, Iss. 3, 2006-06 ,pp. :